Search results
Author(s):
Duk-Woo Park
,
Bill D Gogas
Added:
3 years ago
Dr Bill Gogas, USC's Editor-in-Chief, invites Dr Duk-Woo Park (Asan Medical Center, Seoul, KR) to talk about the long-term data from the MAIN-COMPARE Registry (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) and its relevance to practice.
Editor: Mirjam Boros
View more
Author(s):
Laura Young
,
Jaikirshan Khatri
Added:
2 years ago
Author(s):
Alexander G Truesdell
,
Matheen A Khuddus
,
Sara C Martinez
,
et al
Added:
3 years ago
“When you fail to prepare, you’re preparing to fail.”
– Coach John Wooden
Ongoing technological and procedural innovations increasingly permit the safe and effective performance of ever more high-risk and complex percutaneous coronary interventions (PCI) in the modern cardiac catheterization laboratory. Anatomic characteristics of higher risk include unprotected distal left main stenosis,…
View more
Author(s):
Alan J Bank
,
Kevin V Burns
,
Ryan M Gage
Added:
3 years ago
Cardiac resynchronization therapy (CRT) is a well-accepted and proven therapy for the treatment of patients with advanced heart failure (HF), significant left ventricular (LV) systolic dysfunction, and a wide QRS complex on electrocardiogram (ECG). In this patient population, large multicenter studies have demonstrated that CRT improves symptoms of HF, exercise capacity, LV size and systolic…
View more
Author(s):
Marc P Allard-Ratick
,
Pratik Sandesara
,
Arshed A Quyyumi
,
et al
Added:
3 years ago
Historically, HDL cholesterol (HDL-C) has been inversely associated with adfverse cardiovascular outcomes such as MI, stroke, and cardiovascular death.1–3 This led to widespread belief that HDL-C, in addition to LDL cholesterol (LDL-C), was a modifiable risk factor for cardiovascular disease.
However, efforts to increase HDL-C in high-risk patients with well-controlled LDL-C values have not…
View more
Author(s):
Myung H Park
Added:
3 years ago
Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a progressive increase in pulmonary artery pressure and pulmonary vascular resistance, leading to right ventricular failure and death.1 The recent World Health Organization (WHO) classification designates PAH as Group I and includes idiopathic PAH (IPAH)—formerly known as primary pulmonary hypertension (PPH)…
View more
Author(s):
Giora Weisz
Added:
3 years ago
Much has been written, but little is known, about the long-term outcomes after drug-eluting stent (DES). The introduction of DES has extended the use of stents from a passive platform for vessel wall scaffolding to an active biotechnology vehicle for local delivery of antiproliferative pharmacotherapy. Like any other therapy or medical technology, no treatment is perfect and free of potential…
View more
Author(s):
Colin T Phillips
,
Michael C Gavin
Added:
3 years ago
Acute coronary syndrome (ACS) occurs most often when a vulnerable intracoronary plaque ruptures or erodes to expose a prothrombotic core, precipitating thrombus formation by way of platelet activation,1–3 The spectrum of ACS includes non-ST segment-elevation (NSTE) ACS, where a vulnerable plaque threatens downstream coronary perfusion manifest as an increase in symptom frequency and/or duration …
View more
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more